Dong Sung Bio Pharm.Co.,Ltd. (KRX:002210)

KRX:002210 Revenue

In the year 2011, Dong Sung Bio Pharm.Co.,Ltd. had annual revenue of 78.44B KRW with 9.06% growth. Dong Sung Bio Pharm.Co.,Ltd. had revenue of 18.57B in the quarter ending June 30, 2013, a decrease of -0.97%. That makes Dong Sung Bio Pharm.Co.,Ltd. the 26,730th largest company in the world by revenue and 1,595th in South Korea.

• Revenue: 78.44B
• Revenue Growth: +13.99%
• P/S Ratio: 1.43
• Revenue / Employee: 270.49M
• Employees: 290
• Market Cap: 112.29B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medical Supply Business 68.56B 87.4%
• Cosmetics Business 9.88B 12.6%

By Geography

Chart

• South Korea 73.03B 93.1%
• Overseas 5.41B 6.9%

Fiscal year ended Dec 31, 2011

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2011	78.44B	6.52B	9.06%
Dec 31, 2010	71.93B	3.20B	4.66%
Dec 31, 2009	68.72B	6.49B	10.43%
Dec 31, 2008	62.23B	1.91B	3.17%
Dec 31, 2007	60.32B	-2.61B	-4.15%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2013

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error